Go offline with the Player FM app!
The future of exercise
Manage episode 426099317 series 2712286
Jonathan Long is a biochemist who studies the chemicals produced during exercise. In Long’s world, “you always start with molecules,” which offer “clean handles” to understanding complex processes. His lab has identified a chemical produced in the digestive tract during exercise that can make a person stop eating. Long now studies this “gut-brain axis” for ways to treat obesity, diabetes, and, perhaps, even age-related conditions like dementia, as he tells host Russ Altman on this episode of Stanford Engineering’s The Future of Everything podcast.
Episode Reference Links:
- Stanford Profile: Jonathan Z. Long
- Jonathan’s Lab: LongLab@Stanford
- Study on Endocannabinoids and Exercise Motivation: The Endocannabinoid System and Physical Exercise
Connect With Us:
- Episode Transcripts >>> The Future of Everything Website
- Connect with Russ >>> Threads or Twitter/X
- Connect with School of Engineering >>> Twitter/X
Chapters:
(00:00:00) Introduction
Host Russ Altman introduces guest Jonathan Long, a professor of pathology at Stanford University
(00:02:30) Effective Weight Loss Drugs
The increase of effective weight loss drugs, and the history and development of these GLP-1 receptor agonists.
(00:04:03) Understanding Metabolism and Exercise
Outline of metabolic chemicals released during physical activity and their potential to combat obesity and diabetes.
(00:05:38) Animal Models in Exercise Studies
The use of animal models in exercise studies and the discovery of Lac-Phe.
(00:07:15) Psychological Preparation for Exercise
The psychological aspects of exercise and the involvement of endocannabinoids in exercise motivation.
(00:09:28) Lac-Phe's Role and Mechanism
The role of Lac-Phe and its production in the gut.
(00:12:21) Differences in Exercise Response
Differences in exercise response between trained athletes and untrained individuals.
(00:13:25) Diabetes and Metabolic Diseases
The relationship between diabetes, exercise, and metabolic diseases.
(00:15:29) Lac-Phe as a Potential Therapeutic
The potential of Lac-Phe as a weight loss drug, and parallels to GLP-1 drug development.
(00:16:48) Importance of How Weight is Lost
Whether the method of weight-loss matters, and the importance of preserving lean muscle mass.
(00:19:40) Exercise as Medicine
The concept of exercise as medicine, and defining physical activity at the same resolution as modern medicines.
(00:22:39) Metformin and Exercise Pathways
The unexpected connection between metformin and the Lac-Phe pathway.
(00:24:08) Prospects of an Exercise Pill
The future of an exercise pill, and the scientific challenges associated with its development.
(00:27:33) Conclusion
Connect With Us:
Episode Transcripts >>> The Future of Everything Website
Connect with Russ >>> Threads or Twitter/X
Connect with School of Engineering >>> Twitter/X
283 episodes
Manage episode 426099317 series 2712286
Jonathan Long is a biochemist who studies the chemicals produced during exercise. In Long’s world, “you always start with molecules,” which offer “clean handles” to understanding complex processes. His lab has identified a chemical produced in the digestive tract during exercise that can make a person stop eating. Long now studies this “gut-brain axis” for ways to treat obesity, diabetes, and, perhaps, even age-related conditions like dementia, as he tells host Russ Altman on this episode of Stanford Engineering’s The Future of Everything podcast.
Episode Reference Links:
- Stanford Profile: Jonathan Z. Long
- Jonathan’s Lab: LongLab@Stanford
- Study on Endocannabinoids and Exercise Motivation: The Endocannabinoid System and Physical Exercise
Connect With Us:
- Episode Transcripts >>> The Future of Everything Website
- Connect with Russ >>> Threads or Twitter/X
- Connect with School of Engineering >>> Twitter/X
Chapters:
(00:00:00) Introduction
Host Russ Altman introduces guest Jonathan Long, a professor of pathology at Stanford University
(00:02:30) Effective Weight Loss Drugs
The increase of effective weight loss drugs, and the history and development of these GLP-1 receptor agonists.
(00:04:03) Understanding Metabolism and Exercise
Outline of metabolic chemicals released during physical activity and their potential to combat obesity and diabetes.
(00:05:38) Animal Models in Exercise Studies
The use of animal models in exercise studies and the discovery of Lac-Phe.
(00:07:15) Psychological Preparation for Exercise
The psychological aspects of exercise and the involvement of endocannabinoids in exercise motivation.
(00:09:28) Lac-Phe's Role and Mechanism
The role of Lac-Phe and its production in the gut.
(00:12:21) Differences in Exercise Response
Differences in exercise response between trained athletes and untrained individuals.
(00:13:25) Diabetes and Metabolic Diseases
The relationship between diabetes, exercise, and metabolic diseases.
(00:15:29) Lac-Phe as a Potential Therapeutic
The potential of Lac-Phe as a weight loss drug, and parallels to GLP-1 drug development.
(00:16:48) Importance of How Weight is Lost
Whether the method of weight-loss matters, and the importance of preserving lean muscle mass.
(00:19:40) Exercise as Medicine
The concept of exercise as medicine, and defining physical activity at the same resolution as modern medicines.
(00:22:39) Metformin and Exercise Pathways
The unexpected connection between metformin and the Lac-Phe pathway.
(00:24:08) Prospects of an Exercise Pill
The future of an exercise pill, and the scientific challenges associated with its development.
(00:27:33) Conclusion
Connect With Us:
Episode Transcripts >>> The Future of Everything Website
Connect with Russ >>> Threads or Twitter/X
Connect with School of Engineering >>> Twitter/X
283 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.